Cointime

Cadent Therapeutics

company

About

Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.

  • 11 - 50

Highlights

Total Funding Amount
$5.40M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$5.40M
Industries
Biotechnology,Health Care,Medical Device,Therapeutics,Wellness
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.

It was founded in 2010 and headquartered in Cambridge, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$5.40M
Cadent Therapeutics has raised a total of $5.40M in funding over 2 rounds. Their latest funding was raised on Feb 16, 2012 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 16, 2012 Series A $5.40M 1 Access BridgeGap Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cadent Therapeutics is funded by 1 investors. Access BridgeGap Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Access BridgeGap Ventures Yes Series A
Cointime
เนื้อหา
บริษัท